Sylvia C McKean
Overview
Explore the profile of Sylvia C McKean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McKean S, Deitelzweig S, Sasahara A, Michota F, Jacobson A
J Hosp Med
. 2009 Oct;
4(8 Suppl):S1-7.
PMID: 19830850
No abstract available.
2.
Michota F, Connor P, McKean S, Deitelzweig S, Sasahara A, Jacobson A
J Hosp Med
. 2009 Oct;
4(8 Suppl):S24-30.
PMID: 19830849
No abstract available.
3.
Sasahara A, Michota F, McKean S, Deitelzweig S, Jacobson A
J Hosp Med
. 2009 Oct;
4(8 Suppl):S16-23.
PMID: 19830848
No abstract available.
4.
Deitelzweig S, Sasahara A, Michota F, McKean S, Jacobson A
J Hosp Med
. 2009 Oct;
4(8 Suppl):S8-S15.
PMID: 19830847
No abstract available.
5.
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study
Hacobian M, Shetty R, Niles C, Gerhard-Herman M, Vallurupalli N, Baroletti S, et al.
Clin Appl Thromb Hemost
. 2009 Jan;
16(1):21-5.
PMID: 19147527
We studied the efficacy and safety of an investigational enoxaparin regimen, 1.5 mg/kg once daily, as a bridge to warfarin for the outpatient treatment of acute venous thromboembolism. We undertook...
6.
Spyropoulos A, Brotman D, Amin A, Deitelzweig S, Jaffer A, McKean S
Cleve Clin J Med
. 2008 May;
75 Suppl 3:S17-26.
PMID: 18496913
Cancer patients, especially those undergoing surgery for cancer, are at extremely high risk for developing venous thromboembolism (VTE), even with appropriate thromboprophylaxis. Anticoagulant prophylaxis in cancer surgery patients has reduced...
7.
Deitelzweig S, McKean S, Amin A, Brotman D, Jaffer A, Spyropoulos A
Cleve Clin J Med
. 2008 May;
75 Suppl 3:S27-36.
PMID: 18494224
Patients undergoing major orthopedic surgery--hip or knee arthroplasty, or hip fracture repair--are in the highest risk category for venous thromboembolism (VTE) solely on the basis of the orthopedic procedure itself....
8.
Jaffer A, Amin A, Brotman D, Deitelzweig S, McKean S, Spyropoulos A
Cleve Clin J Med
. 2008 May;
75 Suppl 3:S7-16.
PMID: 18494223
Hospitalized acutely ill medical patients are at high risk for venous thromboembolism (VTE), and clinical trials clearly demonstrate that pharmacologic prophylaxis of VTE for up to 14 days significantly reduces...
9.
Quiroz R, Gerhard-Herman M, Kosowsky J, DeSantis S, Kucher N, McKean S, et al.
Am J Cardiol
. 2006 Aug;
98(4):535-7.
PMID: 16893712
There remains considerable controversy regarding optimal initial warfarin dosing in patients with acute venous thromboembolism. Therefore, an open-label, randomized trial comparing 2 warfarin initiation nomograms (5 vs 10 mg) was...
10.
Schnipper J, Kirwin J, Cotugno M, Wahlstrom S, Brown B, Tarvin E, et al.
Arch Intern Med
. 2006 Mar;
166(5):565-71.
PMID: 16534045
Background: Hospitalization and subsequent discharge home often involve discontinuity of care, multiple changes in medication regimens, and inadequate patient education, which can lead to adverse drug events (ADEs) and avoidable...